CI
STAB

Cowen Inc’s Statera Biopharma, Inc. Common Stock STAB Stock Holding History

Cowen Inc’s Portfolio STAB Stock Details STAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-109,375
Closed – – 286
2016
Q2 		$0 Hold
109,375
– – ﹤0.01% 309
2016
Q1 		$0 Buy
+109,375
New +$368K ﹤0.01% 369

Other funds holding STAB

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
LTFS
Ladenburg Thalmann Financial Services Miami, Florida $15.9B AUM 25.16% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VKH
Virtu KCG Holdings New York $3.6B AUM 17.11% 1-Year Est. Return
BA
BlackRock Advisors Wilmington, Delaware $98.8B AUM 15.8% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Cowen Inc's STAB Position: Q3 2016 in Review

Cowen Inc sold out of Statera Biopharma, Inc. Common Stock (STAB) in Q3 2016, closing a stake of 109,375 shares.

Cowen Inc first reported a position in STAB in Q1 2016 and held it in 2 quarters. The position peaked at $0 in Q2 2016. 21 funds tracked by Wall St. Rank hold STAB as of Q3 2016.

  • Cowen Inc reported no remaining Statera Biopharma, Inc. Common Stock position as of Q3 2016 after selling out during the quarter.
  • Cowen Inc sold 109,375 Statera Biopharma, Inc. Common Stock shares in Q3 2016.
  • Cowen Inc first reported a position in Statera Biopharma, Inc. Common Stock in Q1 2016 and held it in 2 quarters.
  • Cowen Inc's Statera Biopharma, Inc. Common Stock position peaked at $0 in Q2 2016.
  • 21 funds tracked by Wall St. Rank held Statera Biopharma, Inc. Common Stock as of Q3 2016.

Based on Cowen Inc's 13F filing for Q3 2016, filed 14 Nov 2016.